5723 studies found for:    Etopósido OR HIV [CONDITION]
Show Display Options
Rank Status Study
1 Terminated PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
Conditions: HIV-Dementia;   HIV-Associated Cognitive Motor Complex;   AIDS Encephalopathy;   AIDS Dementia Complex;   AIDS-Related Dementia Complex;   HIV Infections;   Healthy
Intervention: Drug: [11C]PBR28
2 Completed Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea
Conditions: HIV Enteropathy;   Diarrhea With HIV
Intervention: Drug: Crofelemer
3 Recruiting A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
Conditions: Kaposi's Sarcoma;   HIV+;   HIV Positive;   AIDS
Intervention: Drug: aldoxorubicin
4 Completed Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS
Conditions: HIV Infections;   Fatigue;   HIV Positive;   AIDS;   Healthy Volunteer;   HV
5 Completed Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
Conditions: HIV Infections;   HIV Positive;   Pregnant Women
6 Enrolling by invitation The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
Conditions: HIV Positive;   Anal Condylomata;   Anal Warts;   HIV Infections
Interventions: Drug: Saline;   Drug: Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
7 Completed Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission
Conditions: HIV Infections;   AIDS;   Sexually Transmitted Diseases;   HIV Seroconversion
Intervention: Drug: Carraguard (PC-515)
8 Completed A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
Conditions: HIV Infections;   HIV Wasting Syndrome
Intervention: Drug: Nandrolone decanoate
9 Completed The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment
Conditions: HIV Positive;   Opioid Dependence;   Opioid Agonist Treatment;   HIV Infections
10 Completed Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
Conditions: HIV Seropositivity;   Kaposi's Sarcoma;   HIV Infections
11 Recruiting CCTG 593: Testing and Linkage to Care
Conditions: HIV Positive;   HIV Seronegative
Intervention: Behavioral: Linkage to PrEP or Care
12 Completed Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
Conditions: HIV Infections;   Involuntary Weight Loss;   Cachexia;   Anorexia;   AIDS Wasting Syndrome;   HIV Wasting Syndrome
Interventions: Drug: Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL;   Drug: Megestrol acetate oral suspension 40 mg/mL
13 Completed A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss
Conditions: HIV Infections;   HIV Wasting Syndrome
Intervention: Drug: Optimune oral nutritional supplement
14 Completed A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome;   HIV Lipodystrophy Syndrome;   Lipodystrophy;   Dyslipidemia;   Osteoporosis;   Osteopenia
15 Completed The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children
Conditions: HIV Infections;   HIV Wasting Syndrome;   Lipodystrophy
16 Completed A Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Medications With the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers
Condition: HIV
Intervention: Drug: Atorvastatin
17 Completed A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells
Condition: HIV Infections
Intervention: Biological: gp160 Vaccine (MicroGeneSys)
18 Completed Safety and Acceptability of Carraguard® in HIV Positive Women and Men
Condition: HIV Infections
Intervention: Drug: Carraguard (PC-515)
19 Completed Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users
Conditions: HIV Infections;   Crack Cocaine Use;   Risky Sexual Behavior
Intervention: Behavioral: Prevention Care Advocate
20 Completed A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals
Condition: HIV Infections
Interventions: Biological: gp160 Vaccine (Immuno-AG);   Biological: Hepatitis B Vaccine (Recombinant)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years